Activation of the skeletal muscle ryanodine receptor by suramin and suramin analogs

Molecular Pharmacology

Volumn 50, Issue 6, 1996, Pages 1443-1453

  Hohenegger, Martin ^a,d   Matyash, Marina ^a   Poussu, Kati ^a   Herrmann Frank, Annegret ^b   Sarközi, Sandor ^b,c   Lehmann Horn, Frank ^b   Freissmuth, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALDEHYDE DERIVATIVE; CALCIUM ION; MAGNESIUM ION; NAPHTHALENESULFONIC ACID DERIVATIVE; PURINE P2 RECEPTOR; RYANODINE RECEPTOR; SURAMIN;

AFFINITY LABELING; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG BINDING SITE; DRUG POTENCY; DRUG RECEPTOR BINDING; LIPID BILAYER; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RABBIT; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION;

ADENINE NUCLEOTIDES; AFFINITY LABELS; ANIMALS; CALCIUM CHANNELS; MUSCLE PROTEINS; MUSCLE, SKELETAL; RABBITS; RADIOLIGAND ASSAY; RYANODINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; STRUCTURE-ACTIVITY RELATIONSHIP; SURAMIN; TRITIUM; TRYPANOCIDAL AGENTS;

EID: 0030480270     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Sorrentino, V., and P. Volpe. Ryanodine receptors: how many, where, and why? Trends Pharmacol. Sci. 14:98-103 (1993).
2. 2+ ions in excitation-contraction coupling of skeletal muscle fibers. Biochim. Biophys. Acta 1241:59-116 (1995).
3. Flucher, B. E., S. B. Andrews, S. Fleischer, A. R. Marks, A. Caswell, and J. A. Powell. Triad formation: organization and function of the sarcoplasmic reticulum calcium release channel and triadin in normal and dysgenic muscle in vitro. J. Cell Biol. 123:1161-1174 (1993).
4. Lu, X., L. Xu, and G. Meissner. Phosphorylation of dihydropyridine receptor II-III loop peptide regulates skeletal muscle calcium release channel function: evidence for an essential role of the β-OH group of Ser687. J. Biol. Chem. 270:18459-18464 (1995).
5. El-Hayek, R., B. Antoniu, J. Wang, S. L. Hamilton, and N. Ikemoto. Identification of calcium-release triggering and blocking regions of the II-III loop of the skeletal muscle dihydropyridine receptor. J. Biol. Chem. 270:22116-22118 (1995).
6. Palade, P., C. Dettbarn, D. Brunder, P. Stein, and G. Hals. Pharmacology of calcium release from sarcoplasmic reticulum. J. Bioenerg. Biomembr. 21:295-320 (1989).
7. Witcher, D. R., R. J. Kovacs, H. Schulmann, D. C. Cefali, and L. R. Jones. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J. Biol. Chem. 266:11144-11152 (1991).
8. Wang, J., and P. M. Best. Inactivation of the sarcoplasmic reticulum calcium channel by protein kinase. Nature (Lond.) 359:739-741 (1992).
9. 2+ release channel activity by phosphorylation of skeletal muscle ryanodine receptor. FEBS Lett. 332:237-242 (1993).
10. Hohenegger, M., and J. Suko. Phosphorylation of the purified cardiac ryanodine receptor by exogenous and endogenous protein kinases. Biochem. J. 296:303-308 (1993).
11. Smith, J. S., R. Coronado, and G. Meissner. Sarcoplasmic reticulum contains adenine nucleotide-activated channels. Nature (Lond.) 316:446-449 (1985).
12. Smith, J. S., R. Coronado, and G. Meissner. Single channel measurements of the calcium release channel from skeletal muscle reticulum. J. Gen. Physiol. 88:573-588 (1986).
13. 2+ release channel of sarcoplasmic reticulum. J. Gen. Physiol. 92:1-26 (1988).
14. Lai, F. A., H. P. Erikson, E. Rousseau, Q. Y. Liu, and G. Meissner. Purification and reconstitution of the calcium release channel from skeletal muscle. Nature (Lond.) 331:315-319 (1988).
15. Zarka, A., and V. Shoshan-Barmatz. Characterization and photoaffinity labeling of the ATP binding site of the ryanodine receptor from skeletal muscle. Eur. J. Biochem. 213:147-154 (1993).
16. Hohenegger, M., A. Herrmann-Frank, M. Richter, and F. Lehmann-Horn. Activation and labeling of the purified skeletal muscle ryanodine receptor by an oxidized ATP analogue. Biochem. J. 308:119-125 (1995).
17. Voogd, T. E., E. L. M. Vansterkenburg, J. Wilting, and L. H. M. Janssen. Recent research on the biological activity of suramin. Pharmacol. Rev. 45:177-203 (1993).
18. Emmick, J. T., Kwon, S., Bidasee, K. R., Mesch, K. T., and Besch, H. R. Dual effect of suramin on calcium fluxes across sarcoplasmic reticulum vesicle membranes. J. Pharmacol. Exp. Ther. 269:717-724 (1994).
19. van Rhee, A. M., M. P. A. van der Heijden, M. W. Beukers, A. P. IJzerman, W. Soudjin, and P. Nickel. Novel competitive antagonists for P2 purinoceptors. Eur. J. Pharmacol. 268:1-7 (1994).
20. Easterbrook-Smith, S. B., J. C. Wallance, and D. B. Keech. Pyruvate carboxylase: affinity labeling of the magnesium adenosine triphosphate binding site. Eur. J. Biochem. 62:125-130 (1976).
21. 2+-ATPase of sarcoplasmic reticulum via the catalytic adenosine nucleotide binding site. Eur. J. Biochem. 205:173-179 (1992).
22. Wyskovsky, W., M. Hohenegger, B. Plank, G. Hellmann, S. Klein, and J. Suko. Activation and inhibition of the calcium-release channel of isolated skeletal muscle heavy sarcoplasmic reticulum: models of the calciumrelease channels. Eur. J. Biochem. 194:549-559 (1990).
23. Herrmann-Frank, A., M. Richter, S. Sarközi, U. Mohr, and F. Lehmann-Horn. 4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor. Biochim, Biophys. Acta 1289:31-40 (1996).
24. Hohenegger, M., C. Nanoff, H. Ahorn, and M. Freissmuth. Structural and functional characterization of the interaction between 2′,3′-dialdehyde guanine nucleotide analogues and the stimulatory G protein α-subunit. J. Biol. Chem. 269:32008-32015 (1994).
25. Kaplan, R. S., and P. L. Pedersen. Determination of microgram quantities of protein in the presence of milligram levels of lipid with amido black 10B. Anal. Biochem. 150:97-104 (1985).
26. Fabiato, A. Computer programs for calculating total from specified free or free from specified total ionic concentration in aqueous solution containing multiple metals and ligands. Methods Enzymol. 157:378-417 (1988).
27. Buck, E., I. Zimanyi, J. J. Abramson, and I. N. Pessah. Ryanodine stabilizes multiple conformational states of the skeletal muscle calcium release channel. J. Biol. Chem. 267:23560-23567 (1992).
28. 2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action. Mol. Pharmacol. 39:679-689 (1991).
29. 2+, caffeine, and adenine nucleotides. Mol. Pharmacol. 31:232-238 (1987).
30. 2+ release channel complex of skeletal muscle sarcoplasmic reticulum: evidence for a cooperatively coupled, negatively charged homotetramer. J. Biol. Chem. 264:16776-16785 (1989).
31. 3H]ryanodine binding to sarcoplasmic reticulum from bullfrog skeletal muscle. J. Biochem. 107:887-893 (1990).
32. 2+ release channel. Am. J. Physiol. 253:C364-C368 (1987).
33. Nagasaki, K., and S. Fleischer. Ryanodine sensitivity of the calcium release channel of sarcoplasmic reticulum. Cell Calcium 9:1-7 (1988).
34. McGrew, S. G., C. Wolleben, M. Inui, and S. Fleischer. Positive cooperativity of ryanodine binding to the calcium release channel of sarcoplasmic reticulum from heart and skeletal muscle. Biochemistry 28:1686-1691 (1989).
35. 3H]ryanodine binding to sarcoplasmic reticulum. J. Biochem. 107:894-898 (1990).
36. 2+ -permeable pore of the calcium release channel. J. Biol. Chem. 262:16636-16643 (1987).
37. Pessah, I. N., A. Francini, D. Scales, A. Waterhouse, and J. E. Casida. Calcium-ryanodine receptor complex: solubilization and partial characterization from skeletal muscle junctional sarcoplasmic reticulum vesicles. J. Biol. Chem. 261:8643-8648 (1986).
38. 2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br. J. Pharmacol. 99:617-621 (1990).
39. Wieringa, R. K., B. Swinkels, P. A. M. Michels, K. Osinga, O. Misset, J. Van Beeumen, W. C. Gibson, J. P. M. Postma, F. R. Opperdoes, and W. G. J. Hol. Common elements on the surface of glycolytic enzymes from Trypanosoma brucei may serve as topogenic signals for import into glycosomes. EMBO J. 6:215-221 (1987).
40. Misset, O., and F. R. Opperdoes. The phosphoglycerate kinase from Trypanosoma brucei: a comparison of the glycosomal and cytosolic isoenzymes and their selectivity towards suramin. Eur. J. Biochem. 162:493-500 (1987).
41. Freissmuth, M., S. Boehm, W. Beindl, P. Nickel, A. P. IJzerman, M. Hohenegger, and C. Nanoff. Suramin analogues as subtype-selective G protein inhibitors. Mol. Pharmacol. 49:602-611 (1996).
42. Beindl, W., T. Mitterauer, M. Hohenegger, A. P. IJzerman, C. Nanoff, M. Freissmuth. Inhibition of receptor/G protein coupling by suramin analogues. Mol. Pharmacol. 50:415-423 (1996).
43. Mack, M. M., I. Zimanyi, and I. P. Pessah. Discrimination of multiple binding sites for antagonists of the calcium release channel complex of the skeletal and cardiac sarcoplasmic reticulum. J. Pharmacol. Exp. Ther. 262:1028-1037 (1992).